Trial Profile
A study to compare the effects of high-dose atorvastatin versus moderate-dose rosuvastatin on lipid parameters, oxidized-LDL and inflammatory markers in patients with myocardial infarction
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Feb 2016
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary) ; Rosuvastatin (Primary)
- Indications Myocardial infarction
- Focus Biomarker; Therapeutic Use
- 05 Feb 2016 New trial record